Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04846374 · ClinicalTrials.gov registry record
Two is Better Than One: A Novel Venous Access System for Intermittent Apheresis
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 20
- Enrollment target
NCT04846374 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 20 participants.
The verdict
NCT04846374 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Purpose: To describe a novel configuration of venous access for the performance of intermittent apheresis. Participants: 20 participants at UNC who were referred for change from a vortex port to a powerflow port. Procedures (methods): Placement of one of two configurations of the powerflow port and follow up visits between January 1, 2019 and December 31, 2023.
Interventions
- DEVICE PowerPort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-05-26 |
| Est. Completion | 2023-04-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04846374
The ClinicalTrials.gov registry entry for NCT04846374 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PowerPort is the first listed.
NCT04846374 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04846374 about?
NCT04846374 is a clinical study titled "Two is Better Than One: A Novel Venous Access System for Intermittent Apheresis". Purpose: To describe a novel configuration of venous access for the performance of intermittent apheresis. Participants: 20 participants at UNC who were referred for change from a vortex port to a powerflow port. Procedures (methods): Placement of one of two configurations of the powerflow port an...
What is the current status of trial NCT04846374?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2021-05-26. Estimated completion is 2023-04-14.
What interventions are being tested in trial NCT04846374?
The interventions under investigation include: PowerPort (DEVICE).
Who is sponsoring clinical trial NCT04846374?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.